dr. forster on recent data with lurbinectedin in sclc
Published 5 years ago • 599 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
1:54
dr. forster on next steps with lurbinectedin in sclc
-
1:02
dr. forster discusses the atlantis study in small-cell lung cancer
-
2:00
dr. west on lurbinectedin in sclc
-
7:39
data on fda approved therapy for relapsed/refractory sclc
-
2:50
dr. farago on effectiveness of single-agent lurbinectedin in sclc
-
4:18
lurbinectedin’s role in managing sclc
-
2:15
no os benefit with lurbinectedin/doxorubicin in sclc - medpage today
-
3:00
small-cell lung cancer: future directions in care
-
1:12
dr. horn discusses next steps with atezolizumab in sclc
-
0:50
efficacy and safety of lurbinectedin in elderly patients with relapsed sclc
-
4:27
emerging treatment options for sclc
-
5:27
asco 2021 lung recap: lurbinectedin in small cell lung cancer and the failed atlantis trial
-
2:01
findings from atlantis: lurbinectedin/doxorubicin vs topotecan or cav in sclc
-
2:01
palliative radiotherapy with lurbinectedin in patients with extensive stage sclc
-
1:05
dr. sabari discusses role of immunotherapy in sclc
-
2:03
chemoradiation and immunotherapy for patients with small cell lung cancer
-
4:58
lurbinectedin in sclc
-
0:38
mary j. fidler, md, on combination lurbinectedin & checkpoint inhibitors in the treatment of sclc